glp-1 news 2025 november nov GLP-1 Receptor Agonist Market Growth Analysis As GLP-1 Drugs Go Mainstream,

In the AMPLITUDE-O post-hoc analysis, the HR for MACE was 0.70 (95% CI 0.371.30) with baseline SGLT2is and 0.74 (95% CI 0.580.94) without SGLT2is ( P -value for interaction 0.70), and the HR for HHF was 0.23 (95% CI 0.050.97) with SGLT2is and 0.70 (95% CI 0.421.17) without SGLT2is ( P -value for interaction 0.35) [47]

Who Should Absolutely Avoid Juniper Several patient profiles carry contraindications so firm that no GLP-1 telehealth program, including Juniper, should initiate treatment

Your transformation starts here!

ROR = 3.44, 95% CI 3.343.55), weight loss (n = 7815

Theres no guidance on changing GLP-1 dosage for weight loss maintenance, but your doctor may be willing to experiment with smaller or less frequent injections

Some people notice greasy, fried, very sugary, carbonated, or large high-volume meals feel less comfortable early on